AG Mednet, a technology company automating and increasing data quality for clinical trials, has announced an expansion to its Submission Quality and Compliance (SQC) Toolkit. The Judi-based integrated image quality control (QC) product functionality gives core laboratories, CROs, and sponsors the most complete and powerful capability to manage site image submissions in record time. Judi is an AG Mednet technology platform designed and built from the ground up for the purpose of managing collaboration activities between different constituencies in the clinical trial ecosystem.
The growth of Judi's SQC toolkit, a component of every Judi // Imaging deployment, includes the newly released DICOM and exam editor which, as a first in the industry, provides powerful tools enabling advanced QC to be completed on medical image submissions. The configurable graphical editor enables not only the 21 CFR Part 11 compliant replacement of DICOM tag content with input validation but allows users to graphically reorganize instances and series throughout an exam, including the creation of new series and visual modification of series boundaries. Judi's DICOM and exam editor provides extensive exam navigation functions, undo capabilities, special features to handle PHI in a compliant manner and the ability to require electronic signatures for audit trail purposes.
Judi's entirely web-based and full featured-medical image viewer is also a component of the SQC toolkit and is integrated into the platform's powerful electronic case report forms (eCRF) system. With Judi // Imaging, radiologists and image reviewers have the ability to mark images and automatically complete eCRF fields. Through the robust intra-form workflow capability, clients can implement complex exam review processes that fit the particular needs of their trials.
"The combination of the newly released DICOM and exam editor together with its web-based viewer and the highly utilized SQC-based automated site-wide quality checks are the foundation of the first-in-market integrated approach to quality in trials using imaging data analysis," said Abraham Gutman, president and CEO of AG Mednet. "We are confident this upgrade will greatly enhance image management operations from the largest imaging CRO to the smallest clinical trial reading service as well as sponsors interested in ‘collect and hold' trials. Judi // Imaging manages clinical trial images through their entire lifecycle, in one platform that is all-inclusive and the proven system of choice."
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Anselamimab Misses Primary Endpoint in Phase III CARES Trials for AL Amyloidosis
July 17th 2025In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a prespecified subgroup analysis revealed meaningful improvements in survival and cardiovascular outcomes.